Legal and Regulatory Considerations FDA Stance on Compounded GLP-1 Medications The FDA has expressed concerns about the safety of compounded semaglutide products
Others benefit from faster dose increases or higher maintenance doses
But aside from those that are approved as therapeutic medications, the manufacturing of certain peptides is largely unregulated
Role of funding source: The funders of the study had no role in the study design, data collection, data analysis, data interpretation, or writing of the report
DISCLAIMER Prescription medications are only available after completing an online consultation with a licensed healthcare provider
Despite pharmacies largely having to stop making the drug in mid-March, it is still being offered on many platforms, including Mochi Health